Daewoong Pharma Cash Flow Reinvestment Rate
Daewoong Pharma cash flow reinvestment rate. Daewoong Pharma (069620) has a Cash Flow Reinvestment Rate of 1.26x as of September 2025, reinvesting ₩72.66 Billion (capex ₩72.21 Billion plus investments ₩-447.40 Million) from operating cash flow of ₩57.53 Billion. See 069620 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Daewoong Pharma (2007–2024)
Cash flow reinvestment rate of Daewoong Pharma from 2007 to 2024. Historical reinvestment intensity for Daewoong Pharma across 16 annual periods. Explore 069620 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Daewoong Pharma Cash Flow Reinvestment Rate by Year (2007–2024)
Daewoong Pharma cash flow reinvestment rate by year from 2007 to 2024. Year-by-year capital reinvestment analysis for Daewoong Pharma. For the full cash flow conversion analysis, see 069620 cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 5.11x | ₩263.16 Billion | ₩51.49 Billion | ₩229.00 Billion | ▲ +120.7% |
| 2023 | 2.32x | ₩306.94 Billion | ₩132.57 Billion | ₩118.67 Billion | ▲ +279.0% |
| 2022 | 0.61x | ₩72.21 Billion | ₩118.21 Billion | ₩65.23 Billion | ▼ -42.3% |
| 2021 | 1.06x | ₩42.31 Billion | ₩39.99 Billion | ₩29.09 Billion | ▼ -6.4% |
| 2020 | 1.13x | ₩114.07 Billion | ₩100.98 Billion | ₩26.49 Billion | ▲ +7.3% |
| 2019 | 1.05x | ₩60.66 Billion | ₩57.60 Billion | ₩22.31 Billion | ▼ -33.4% |
| 2018 | 1.58x | ₩75.09 Billion | ₩47.50 Billion | ₩56.99 Billion | ▲ +77.9% |
| 2017 | 0.89x | ₩92.38 Billion | ₩103.94 Billion | ₩69.12 Billion | ▼ -95.7% |
| 2016 | 20.75x | ₩319.02 Billion | ₩15.38 Billion | ₩163.25 Billion | ▲ +506.1% |
| 2015 | 3.42x | ₩122.84 Billion | ₩35.89 Billion | ₩95.13 Billion | ▼ -29.9% |
| 2014 | 4.89x | ₩126.78 Billion | ₩25.95 Billion | ₩46.00 Billion | ▲ +343.6% |
| 2013 | 1.10x | ₩59.65 Billion | ₩54.16 Billion | ₩19.04 Billion | ▲ +108.6% |
| 2012 | 0.53x | ₩23.77 Billion | ₩45.02 Billion | ₩23.77 Billion | ▲ +1.7% |
| 2011 | 0.52x | ₩40.92 Billion | ₩78.82 Billion | ₩40.92 Billion | ▼ -54.0% |
| 2008 | 1.13x | ₩35.35 Billion | ₩31.33 Billion | ₩35.35 Billion | ▼ -18.8% |
| 2007 | 1.39x | ₩35.89 Billion | ₩25.81 Billion | ₩35.89 Billion | — |